Speakers: Bruce Larson, PhD and Nafisa Halim, PhD Research Professor and Research Assistant Professor, Department of Global Health, BUSPH Antiretroviral therapy (ART) in HIV-infected women before, during, and after pregnancy is a proven, effective intervention for the prevention-of-mother-to-child-transmission (PMTCT) of HIV. In addition to preventing transmission, ART reduces the severity of the mother’s HIV infection during pregnancy and after delivery (e.g., through viral suppression), which is associated with health outcomes for HIV-exposed but uninfected infants. Existing data suggest, however, that initiation of and retention on ART is less than optimal along the PMTCT cascade of care (CC). The primary objectives of the implementation research study titled the Enhanced Mentor Mother Approach (EMMA) was to: (1) evaluate implementation of routine PMTCT service delivery using the proportion of days covered (PDC) during key periods in PMTCT CC; and (2) evaluate potential benefits of an intervention to adjust priorities of existing peer counselors (called Mentor Mothers) to improve ART coverage. PDC allows ART coverage to be measured consistently across time for both treatment naïve and experienced pregnant women presenting for prenatal care. This event is open to all SPH faculty, staff, and students. Please see the Zoom link below: https://zoom.us/j/432494046 Meeting ID: 432 494 046